Researcher Background
Primary Academic Title
Instructor, Department of Internal Medicine, WashU Medicine
Training
- 2018 - 2020: Resident, Internal Medicine, Barnes-Jewish Hospital, WashU Medicine, St. Louis, MO
- 2020 - 2024: Fellow, Hematology and Oncology, Barnes-Jewish Hospital, WashU Medicine, St. Louis, MO
Education
- 2009: BA, Harvard College, Cambridge, MA
- 2016: PhD, University of California, San Diego, CA
- 2018: MD, University of California, San Diego, CA
Research & Selected Publications
Research Interest
Dr. Kramer is a physician-scientist studying blood cancers, particularly acute myeloid leukemia (AML). He published a proteomic and phosphoproteomic study of AML that identified examples of posttranscriptionally regulated proteins in patients with recurrent AML driver mutations, and identified cell surface proteins that may be targets for immunologic therapies. He is utilizing protein-protein interaction screening to identify protein interactions with oncogenic driver proteins that can be targeted therapeutically, and is utilizing machine learning to predict and design molecules that interact with oncogenic driver proteins. Clinically, Dr. Kramer sees patients with blood cancers on the inpatient Hematologic Malignancies service.
Research Publications